News Releases

ITUS Executive Chairman Dr. Amit Kumar Appointed to American Cancer Society National Board of Directors

November 30, 2016

ITUS Demonstrates Efficacy of its Cchek(TM) Early Cancer Detection Platform with 6 Additional Cancer Types

November 15, 2016

ITUS Demonstrates Efficacy of its Cchek(TM) Early Cancer Detection Platform with Pancreatic Cancer

October 25, 2016

ITUS Hires Michael Catelani as Chief Financial Officer

October 24, 2016

ITUS Receives Notice of NASDAQ Continued Listing Compliance

October 17, 2016

ITUS Demonstrates Efficacy of Its Cchek(TM) Early Cancer Detection Platform With Thyroid Cancer

October 12, 2016

ITUS Demonstrates Efficacy of Its Cchek(TM) Early Cancer Detection Platform With Liver Cancer

October 3, 2016

ITUS Demonstrates Efficacy of Its Cchek(TM) Early Cancer Detection Platform With Ovarian Cancer

September 30, 2016

ITUS Demonstrates Efficacy of Its Cchek(TM) Early Cancer Detection Platform With Melanoma

September 28, 2016

ITUS Demonstrates Efficacy of Its Cchek(TM) Early Cancer Detection Platform With Colon Cancer

September 26, 2016

Latest News & Events

Dec 2, 2019

Anixa Biosciences Announces Presentation at the 2019 San Antonio Breast Cancer Symposium

Read More...

Nov 26, 2019

Anixa Biosciences Announces Genesis Research to Join Cchek™ Prostate Cancer Study

Read More...

Nov 22, 2019

Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek™ Prostate Cancer Study

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.